{{Drugbox
| Watchedfields = changed
| verifiedrevid = 446619973
| IUPAC_name = 4-methoxynaphthalen- 1-yl- (1-pentylindol- 3-yl)methanone
| image = JWH-081.svg

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = Schedule II
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = Schedule I
| legal_DE = Anlage II
| legal_status = I-N (Poland)<ref>{{cite web | title = Ustawa z dnia 15 kwietnia 2011 r. o zmianie ustawy o przeciwdziałaniu narkomanii (Dz.U. 2011 nr 105 poz. 614) |url= http://isap.sejm.gov.pl/DetailsServlet?id&#61;WDU20111050614 |publisher= Internetowy System Aktów Prawnych |accessdate= 12 June 2011}}</ref>
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 210179-46-7
| ATC_prefix =  
| ATC_suffix =  
| PubChem = 10547208
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID      = 8722599

<!--Chemical data-->
| C=25 | H=25 | N=1 | O=2 
| molecular_weight = 371.47 g/mol
| smiles = CCCCCn3c1ccccc1c(c3)C(=O)c4c2ccccc2c(OC)cc4
| StdInChI          = 1S/C25H25NO2/c1-3-4-9-16-26-17-22(19-11-7-8-13-23(19)26)25(27)21-14-15-24(28-2)20-12-6-5-10-18(20)21/h5-8,10-15,17H,3-4,9,16H2,1-2H3
| StdInChIKey       = UBMPKJKGUQDHRM-UHFFFAOYSA-N

}}
'''JWH-081''' is an [[analgesic]] chemical from the [[naphthoylindole]] family, which acts as a [[cannabinoid]] agonist at both the CB<sub>1</sub> and CB<sub>2</sub> receptors.<ref>Aung MM, ''et al.'' Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB<sub>1</sub> and CB<sub>2</sub> receptor binding. ''Drug and Alcohol Dependence'' 2000; 60:133-140.</ref> With a [[dissociation constant|K<sub>i</sub>]] of 1.2nM it is fairly selective for the CB<sub>1</sub> subtype, its affinity at this subtype approximately 10x the affinity at CB<sub>2</sub>.<ref>Huffman JW, ''et al.'' Structure–activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB<sub>1</sub> and CB<sub>2</sub> receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB<sub>2</sub> receptor agonists. ''Bioorganic & Medicinal Chemistry''. 2005; 13:89-112.</ref> It was discovered by and named after Dr. [[John W. Huffman]].

JWH-081 may be neurotoxic to animals when administered in high doses.<ref>{{cite journal | title=Neurotoxicity of Synthetic Cannabinoids JWH-081 and JWH-210 |author1=Hye Jin Cha |author2=Yeon-Hee Seong |author3=Min-Ji Song |author4=Ho-Sang Jeong |author5=Jisoon Shin |author6=Jaesuk Yun |author7=Kyoungmoon Han |author8=Young-Hoon Kim |author9=Hoil Kang |author10=Hyoung Soo Kim | journal=Biomolecules & Therapeutics | date=November 2015 | volume=23 | issue=6 | pages=597–603 | doi=10.4062/biomolther.2015.057 | pmid=26535086 | pmc=4624077}}</ref>

==Legal Status==

As of October 2015 JWH-081 is a controlled substance in China.<ref>{{cite web | url=http://www.sfda.gov.cn/WS01/CL0056/130753.html | title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知 | publisher=China Food and Drug Administration | date=27 September 2015 | language=Chinese | accessdate=1 October 2015}}</ref>

==See also==
*[[JWH-018]]
*[[JWH-098]]
*[[JWH-164]]
*[[JWH-198]]
*[[JWH-210]]

==References==
{{reflist}}

{{Cannabinoids}}
{{Hallucinogens}}

[[Category:Designer drugs]]
[[Category:JWH cannabinoids]]
[[Category:Naphthoylindoles]]
[[Category:Phenol ethers]]
[[Category:CB1 receptor agonists]]


{{cannabinoid-stub}}